Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

05. Februar 2015 16:05 ET | Quelle: Dermira, Inc.

Dermira Announces Positive Phase 2b Results for DRM04 in Patients With Hyperhidrosis

MENLO PARK, Calif., Feb. 5, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
29. Januar 2015 16:05 ET | Quelle: Dermira, Inc.

Dermira to Present at the 2015 Leerink Global Healthcare Conference

MENLO PARK, Calif., Jan. 29, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
08. Januar 2015 02:00 ET | Quelle: Dermira, Inc.

Dermira and UCB Announce Start of Phase 3 Program for CIMZIA(R) (certolizumab pegol) in Psoriasis

Phase 3 program aims to address patient need for alternative treatment options in moderate-to-severe psoriasis Program includes the first Phase 3 study in psoriasis comparing two...
22. Dezember 2014 08:00 ET | Quelle: Dermira, Inc.

Dermira Added to Russell 2000(R) Index

MENLO PARK, Calif., Dec. 22, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...
12. November 2014 16:05 ET | Quelle: Dermira, Inc.

Dermira Reports Third Quarter 2014 Financial Results and Provides Corporate Update

REDWOOD CITY, Calif., Nov. 12, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology...
02. Oktober 2014 21:37 ET | Quelle: Dermira, Inc.

Dermira Prices Initial Public Offering

REDWOOD CITY, Calif., Oct. 2, 2014 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated medical dermatology products...